What Your MyUTI Report Tells You—and Why It Matters More Than Ever
If you’ve recently ordered a test with MyUTI, you may have noticed something different—and better—about your results report. We’ve redesigned it to not only improve clarity and accessibility, but also to deliver even more critical insights. With the launch of our expanded UTI panel and detection of more antimicrobial resistance genes (ARGs), your report now offers a deeper look into the bacteria causing your infection and the treatments that are most likely (or unlikely) to work.
This new report is a powerful clinical tool, designed to bring you and your healthcare provider the information needed to make faster, more personalized decisions. Alongside updated visuals and simplified explanations, you’ll find clear indications of which antibiotics your detected bacteria may resist—helping to avoid trial-and-error prescriptions that don’t work.
📝 Download or print your full Report Reference Guide here for a step-by-step walk-through of the new report layout, how to read resistance flags, and how to share the data with your doctor.
In this post, we’ll break down what’s changed, why it matters for your health, and how our expanded detection is helping more people find relief faster—with confidence backed by science.
What’s New in the Report: A Closer Look
1. Bacterial Detection Levels
Our updated report now clearly shows how much of each pathogen was detected—information that can help differentiate between colonization and infection. Understanding these levels can help guide more precise clinical conversations, especially when symptoms are persistent or complex.
2. Expanded Antimicrobial Resistance Gene (ARG) Panel
One of the biggest upgrades is our expanded panel of antimicrobial resistance genes. These ARGs help determine whether the bacteria present may be resistant to common antibiotics, including sulfonamides, beta-lactams, fluoroquinolones, macrolides, and more.
Why it matters: The presence of these genes can predict resistance even before a prescription is written, which helps avoid antibiotics that won’t work—and gets you closer to one that will.
3. Antibiotic Guidance You Can Bring to Your Provider
The report flags the antibiotics most likely to be ineffective based on detected resistance genes. That means your provider can use this data to make more informed treatment decisions—faster. We’ve made this section easier to read and easier to share, with clear callouts for common drug classes and individual names.
4. Simplified Language and Visual Design
We know that test results can be overwhelming—especially when you’re not feeling your best. The refreshed layout now includes detailed treatment descriptions, clean visuals, and guided footnote sections that explain what you’re looking at and why it matters.
How To Read The MyUTI Report
Want to know how to interpret your personalized MyUTI test results? Watch this quick, step-by-step video guide.
Microorganisms Detected section lists any bacteria found in your sample, along with the amount detected. The quantities are measured in colony-forming units per milliliter—or cfu/mL—and help indicate how much of the organism is present.
Antibiotic Resistance Genes—known as ABRs. These genes can affect how well certain medications work. If an ABR is found, it’s clearly shown here so you and your healthcare provider can make informed decisions.
The Primary Drug listed is the most effective treatment option based on the bacteria found, resistance genes, and current clinical guidelines.
Susceptible identifies the bacteria likely to respond to each medication. This helps indicate the potential effectiveness of the treatment options listed.
The Secondary or Combo Drug is another option that may be used alone or in combination with the primary drug if needed.
Drugs not tested for ABR but commonly used shows a medication that’s commonly recommended based on clinical guidelines. While it's considered appropriate for the detected bacteria, antibiotic resistance genes were not tested in the lab for this drug—so clinical judgment is key when considering its use.
Why Expanded Resistance Detection Changes the Game
Urinary tract infections are becoming harder to treat, with rising rates of antibiotic resistance reported across the U.S. For too many people, the standard test-and-treat model has meant repeated infections, delayed care, or prescriptions that simply don’t work.
By testing for more resistance genes, the MyUTI test now helps detect and sidestep these treatment pitfalls. Whether this is your first infection or your fifth, having personalized resistance data means you and your provider can pursue the most effective treatment faster.
Take Control With Confidence
With this upgraded report, you’re not just getting lab results—you’re getting a personalized roadmap that can support better outcomes and fewer recurrences.
👉 Click here to download your Report Reference Guide for a complete breakdown of the new features and how to use your results when speaking with your healthcare provider.
Got questions about the new report or how it works? Connect with our team at support@myuti.com.
